 |
|
(PROH-teen... PAK-lih-TAK-sil)
| | A drug used to treat breast cancer that has spread or that has come back within 6 months after chemotherapy. It is also being studied in the treatment of newly diagnosed breast cancer and other types of cancer. Protein-bound paclitaxel is a type of mitotic inhibitor. Also called ABI-007, Abraxane, nanoparticle paclitaxel, and paclitaxel albumin-stabilized nanoparticle formulation. |
| Previous Definitions: | protective factor, protegrin, protein, protein expression, protein kinase C | | Next Definitions: | proteoglycan, proteomic profile, proteomics, Protocel, protocol |
|
|
